User: Guest  Login
Document type:
journal article 
Author(s):
Schaller, Stefan Josef; Fink, Heidrun 
Title:
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. 
Abstract:
Sugammadex is the first clinical representative of a new class of drugs called selective relaxant binding agents. It has revolutionized the way anesthesiologists think about drug reversal. Sugammadex selectively binds rocuronium or vecuronium, thereby reversing their neuromuscular blocking action. Due to its 1:1 binding of rocuronium or vecuronium, it is able to reverse any depth of neuromuscular block. So far, it has been approved for use in adult patients and for pediatric patients over 2 year...    »
 
Journal title abbreviation:
Core Evid 
Year:
2013 
Journal volume:
Pages contribution:
57-67 
Language:
eng 
Print-ISSN:
1555-1741 
TUM Institution:
Klinik für Anästhesiologie